Longevity Acquisition, a blank check company focusing on acquiring a business in China, filed for its IPO on Wednesday.
The Shanghai, China-based company plans to raise $40 million by offering 4 million units at a price of $10. Each unit will consist of one share of common stock, one right for one tenth of one share of common stock, and one warrant to purchase one half of a share of common stock. At $10, Longevity Acquisition would command a fully diluted market value of $53 million.
Longevity Acquisition was founded in 2018 and plans to list on the Nasdaq under the symbol LOACU. Cantor Fitzgerald is the sole bookrunner on the deal. No pricing terms were disclosed.
